Business Description
![Salarius Pharmaceuticals Inc Salarius Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C0000ASXO.png?14)
Salarius Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US33938A1051
Description
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 37.38 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | -0.01 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 31.3 | |||||
3-Year EPS without NRI Growth Rate | 33.3 | |||||
3-Year FCF Growth Rate | 38 | |||||
3-Year Book Growth Rate | -61.4 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 15.6 | |||||
9-Day RSI | 20.71 | |||||
14-Day RSI | 25.43 | |||||
6-1 Month Momentum % | -29.15 | |||||
12-1 Month Momentum % | -64.84 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.91 | |||||
Quick Ratio | 3.91 | |||||
Cash Ratio | 3.54 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -60.5 | |||||
Shareholder Yield % | -463.34 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -153.77 | |||||
ROA % | -106.19 | |||||
ROIC % | -3608.9 | |||||
ROCE % | -159.45 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.35 | |||||
Price-to-Tangible-Book | 0.35 | |||||
EV-to-EBIT | 0.31 | |||||
EV-to-EBITDA | 0.31 | |||||
EV-to-FCF | 0.26 | |||||
Price-to-Net-Current-Asset-Value | 0.36 | |||||
Price-to-Net-Cash | 0.41 | |||||
Earnings Yield (Greenblatt) % | 322.58 | |||||
FCF Yield % | -776.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SLRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Salarius Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -19.92 | ||
Beta | 0.22 | ||
Volatility % | 68.89 | ||
14-Day RSI | 25.43 | ||
14-Day ATR ($) | 0.362289 | ||
20-Day SMA ($) | 3.114365 | ||
12-1 Month Momentum % | -64.84 | ||
52-Week Range ($) | 2.3 - 12.48 | ||
Shares Outstanding (Mil) | 0.6 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Salarius Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Salarius Pharmaceuticals Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Salarius Pharmaceuticals Inc Frequently Asked Questions
What is Salarius Pharmaceuticals Inc(SLRX)'s stock price today?
The current price of SLRX is $2.38. The 52 week high of SLRX is $12.48 and 52 week low is $2.30.
When is next earnings date of Salarius Pharmaceuticals Inc(SLRX)?
The next earnings date of Salarius Pharmaceuticals Inc(SLRX) is 2024-08-09 Est..
Does Salarius Pharmaceuticals Inc(SLRX) pay dividends? If so, how much?
Salarius Pharmaceuticals Inc(SLRX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |